
Policy Views
Discover our articles
Posted on 23.06.2025
IVDR reforms: an opportunity to create a system fit for the future


By Anna Hallersten, Head Regulatory Policy Europe, Roche Diagnostics
Posted on 19.05.2025
A golden age of ageing: how Europe can outpace its growing healthcare needs


By Gavin Wood, Company Group Chairman, Johnson & Johnson MedTech EMEA
Posted on 08.05.2025
Patients and doctors express confidence in the medtech revolution


By Julia Fishman, Head of Digital Solutions, Johnson & Johnson MedTech EMEA
Posted on 05.05.2025
Will the EU Health Technology Assessment Regulation boost medtech innovation?


By Andrea Rappagliosi, Senior Vice President Public Affairs EMECLA, Edwards Lifesciences
Posted on 29.04.2025
Wanted: clear assessment criteria for digital health technologies


By Katarzyna Markiewicz-Barreaux, AI Strategic Intelligence Lead, Philips
Posted on 10.01.2025
MDR/IVDR Article 10a – A new bureaucratic challenge for manufacturers you may have missed


By Frank Matzek, Vice President Regulatory & Governmental Affairs, BIOTRONIK
Posted on 07.01.2025
Third-party litigation in Europe: could it fuel a US-style class action culture?


By Pablo Rojas Abad, Senior Legal Counsel, MedTech Europe
Posted on 08.11.2024
Can Europe unlock the power of data while protecting privacy?


By Renate van Kempen, Data Anonymisation Expert and Data Scientist
Posted on 07.11.2024
Beyond the checkbox: My views on compliance


By Samih Al Mawass, Abbott, Divisional Vice President, Abbott Vascular for Europe, Middle East and Africa
Posted on 06.11.2024
The landmark AI Act, its ripple effects on the medical technology industry and the challenges yet to be tackled


By Alexander Olbrechts, Director Digital Health, MedTech Europe
Posted on 12.10.2024
From burden to breakthrough: Orthopaedic innovations for osteoarthritis care


By Andrew Dalton, EMEA Vice President, Johnson & Johnson MedTech, Orthopaedics